Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Net Cash Flow (2019 - 2026)

InMed Pharmaceuticals has reported Net Cash Flow over the past 5 years, most recently at -$2.4 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 9.83% year-over-year to -$2.4 million; the TTM value through Dec 2025 reached $3.5 million, up 157.81%, while the annual FY2025 figure was $4.5 million, 292.42% up from the prior year.
  • Net Cash Flow for Q4 2025 was -$2.4 million at InMed Pharmaceuticals, down from -$1.7 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $8.0 million in Q3 2021 and troughed at -$5.4 million in Q1 2022.
  • A 5-year average of -$252946.8 and a median of -$1.4 million in 2024 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: tumbled 348.26% in 2023 and later soared 721.59% in 2025.
  • Year by year, Net Cash Flow stood at -$4.1 million in 2021, then soared by 164.03% to $2.6 million in 2022, then plummeted by 171.02% to -$1.8 million in 2023, then decreased by 17.07% to -$2.2 million in 2024, then decreased by 9.83% to -$2.4 million in 2025.
  • Business Quant data shows Net Cash Flow for INM at -$2.4 million in Q4 2025, -$1.7 million in Q3 2025, and $6.4 million in Q2 2025.